Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures
Status:
Completed
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
A randomized controlled clinical trial comparing patient/ ER physician satisfaction and ease
of administration of 3 non IV routes of midazolam as a rescue medication for seizure control.
Study population included children with known seizure disorder who were prescribed midazolam
by pediatric neurologist at home and those presenting to ER with following inclusion and
exclusion criteria